Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65580 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Apremilast Desphthalyl Amine ((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C12H19NO4SCouleur et forme :White Off-White SolidMasse moléculaire :273.10348Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H42N4O5Couleur et forme :Off-White SolidMasse moléculaire :562.31552Aminophenylmorpholin-2-one (4-(4-aminophenyl)morpholin-2-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :Pale Yellow SolidMasse moléculaire :192.08988Apremilast Open Ring 3-acetamide ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C22H26N2O8SCouleur et forme :Off-White SolidMasse moléculaire :478.140994-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,4-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :Off-White PowderMasse moléculaire :273.068725-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :White PowderMasse moléculaire :309.04542-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.08437Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20FNO3·HClCouleur et forme :White PowderMasse moléculaire :365.1194Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.07613Ranitidine Hydrochloride
CAS :Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormule :C13H22N4O3S·HClCouleur et forme :White Pale Yellow PowderMasse moléculaire :350.11794Dasatinib Related Compound B (N-(2-Chloro-6-methylphenyl)-2-{[2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl]amino}thiazole-5-carboxamide)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C20H22ClN7OSCouleur et forme :White Off-White PowderMasse moléculaire :443.12951Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :White Off-White SolidMasse moléculaire :195.91526Ondansetron
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C18H19N3OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS :Sulfonamides, nesoiFormule :C23H31N7O7SCouleur et forme :White PowderMasse moléculaire :549.20057Levetiracetam
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White PowderMasse moléculaire :170.10553Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H22N2O6SCouleur et forme :Yellow PowderMasse moléculaire :418.11986Aripiprazole Hydroxydihydroquinolinone Analog (7-hydroxy-3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C9H9NO2Couleur et forme :White Off-White SolidMasse moléculaire :163.06333Fluphenazine Hydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C22H26F3N3OS·2ClHCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :509.12822Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.08202Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White PowderMasse moléculaire :381.07588Polyvinyl Alcohol
CAS :Polyvinyl alcohols, whether or not containing unhydrolyzed acetate groupsFormule :H(C2H4O)m(C4H6O2)nHCouleur et forme :PowderMasse moléculaire :46.0684Fluphenazine Decanoate Dihydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C32H44F3N3O2S·2HClCouleur et forme :White PowderMasse moléculaire :663.26399Omeprazole Magnesium
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H36MgN6O6S2Couleur et forme :White Off-White PowderMasse moléculaire :712.19882Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4SCouleur et forme :White Off-White SolidMasse moléculaire :409.0863Darunavir System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :PowderOxcarbazepine Related Compound A (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H12N2O3Couleur et forme :Pale Yellow PowderMasse moléculaire :280.08479Methyl Alcohol
CAS :Methanol (methyl alcohol)Formule :CH4OCouleur et forme :Colorless Clear LiquidMasse moléculaire :32.02621Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClOSCouleur et forme :Brown LiquidMasse moléculaire :145.95931Duloxetine Hydrochloride
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :White Off-White PowderMasse moléculaire :297.11874Clioquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5ClINOCouleur et forme :PowderMasse moléculaire :304.91044Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H14FN·HClCouleur et forme :White PowderMasse moléculaire :191.11103Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7Couleur et forme :Pale Yellow SolidMasse moléculaire :704.87Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.104232-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H9NOCouleur et forme :Brown LiquidMasse moléculaire :123.06841Sunitinib Malate
CAS :Lactams not elsewhere specified or includedFormule :C22H27FN4O2·C4H6O5Couleur et forme :Yellow Orange PowderMasse moléculaire :532.23333Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Regorafenib
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H15ClF4N4O3·H2OCouleur et forme :White Brown PowderMasse moléculaire :500.08745Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H25N3O5S2Couleur et forme :White PowderMasse moléculaire :427.12356Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO3Couleur et forme :White Off-White SolidMasse moléculaire :399.27734Oxprenolol Hydrochloride
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C15H23NO3·HCICouleur et forme :White PowderMasse moléculaire :405.08009Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H6F3NCouleur et forme :White Light Yellow LiquidMasse moléculaire :161.04523Amiodarone Hydrochloride
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H29I2NO3·HClCouleur et forme :White PowderMasse moléculaire :681.78 g/mol5-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.02694Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C17H23N3OCouleur et forme :Off-White PowderMasse moléculaire :285.18411R-Levetiracetam Hydroxybutyramide Analog ((R)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H16N2O3Couleur et forme :White Off-White SolidMasse moléculaire :188.11609Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormule :C23H37N7O5SCouleur et forme :Off-White PowderMasse moléculaire :523.25769Nilotinib Related Compound A (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C11H10F3N3Couleur et forme :Beige PowderMasse moléculaire :241.08268Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5Cl2NOCouleur et forme :White Off-White PowderMasse moléculaire :212.97482Benzyl Alcohol
CAS :Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formule :C7H8OCouleur et forme :Colorless Clear LiquidMasse moléculaire :108.14 g/molDehydroargatroban Trifluoroacetate ((2R,4R)-4-Methyl-1-{[(3-methylquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid Trifluoroacetate)
Sulfonamides, nesoiFormule :C23H32N6O5S·C2HF3O2Couleur et forme :Off-White PowderMasse moléculaire :504.21549Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051Everolimus
CAS :Antibiotics nesoiFormule :C53H83NO14Couleur et forme :White Yellow PowderMasse moléculaire :957.58136Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :Off-White SolidMasse moléculaire :297.11874Levetiracetam Crotonamide ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide)
CAS :Lactams, nesoiFormule :C8H12N2O2Couleur et forme :White Off-White SolidMasse moléculaire :168.08988Rotigotine Related Compound C ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19NOS·HClCouleur et forme :Light Grey SolidMasse moléculaire :309.09541Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H23NO2Couleur et forme :Off-White SolidMasse moléculaire :273.17288Bendroflumethiazide
CAS :Sulfonamides used as drugsFormule :C15H14F3N3O4S2Couleur et forme :PowderMasse moléculaire :421.42Monoiodoamiodarone ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H30INO3Couleur et forme :Colorless Semi-SolidMasse moléculaire :519.12704Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H21N3O3Couleur et forme :White Off-White SolidMasse moléculaire :279.15829Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H19NO·HClCouleur et forme :White PowderMasse moléculaire :241.12334Fluticasone Propionate
CAS :Halogenated derivatives of adrenal cortical hormonesFormule :C25H31F3O5SCouleur et forme :White PowderMasse moléculaire :500.18443Apremilast Related Compound E ((S)-N-{2-[1-(4-Ethoxy-3-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxoisoindolin-4-yl}acetamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C22H24N2O7SCouleur et forme :Pale Yellow PowderMasse moléculaire :460.13042Brivaracetam Related Compound C ((R)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White SolidMasse moléculaire :212.15248Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13NOCouleur et forme :White Powder ClumpyMasse moléculaire :199.09971Aminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C17H26F3N3O2·2HClCouleur et forme :White PowderMasse moléculaire :433.15107Celecoxib
CAS :Sulfonamides used as drugsFormule :C17H14F3N3O2SCouleur et forme :PowderMasse moléculaire :381.07588Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C32H30N4O8Couleur et forme :Pale Yellow SolidMasse moléculaire :598.20636Paroxetine Methoxy (3R,4S)-Enantiomer Hydrochloride ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H23NO4·HClCouleur et forme :White Off-White SolidMasse moléculaire :341.16271Ambrisentan Related Compound A (4,6-Dimethyl-2-(methylsulfonyl)pyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C7H10N2O2SCouleur et forme :Off-White Light Brown Crystalline PowderMasse moléculaire :186.0463Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.24929Leflunomide
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White PowderMasse moléculaire :270.06161Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :415.27226Norepinephrine Bitartrate
CAS :Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormule :C8H11NO3·C4H6O6·H2OCouleur et forme :White Light Grey Crystalline PowderMasse moléculaire :337.1009Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)
CAS :Halogenated derivatives of adrenal cortical hormonesFormule :C25H32F2O5SCouleur et forme :White Off-White PowderMasse moléculaire :482.19385Paroxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White PowderChloro N-methylthiophene Carboxamide (5-chloro-N-methylthiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H6ClNOSCouleur et forme :White Off-White SolidMasse moléculaire :174.98586Bupropion Hydrochloride Related Compound C (1-(3-chlorophenyl)-2-hydroxypropan-1-one)
CAS :Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormule :C9H9O2ClCouleur et forme :LiquidMasse moléculaire :184.02911Apremilast R-Enantiomer
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C22H24N2O7SCouleur et forme :White Off-White PowderMasse moléculaire :460.13042Fesoterodine Fumarate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C4H4O4Couleur et forme :White Off-White PowderMasse moléculaire :527.2883Clozapine Resolution Mixture
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :Yellow Crystalline PowderMasse moléculaire :203.09061Saxagliptin Related Compound A (Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H25N3O2Couleur et forme :White Fine PowderMasse moléculaire :315.19468Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C24H21F2NO3Couleur et forme :White Off-White SolidMasse moléculaire :409.14895Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C8H8N2OSCouleur et forme :White Off-White PowderMasse moléculaire :180.03573O-Desmethylmetoprolol (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C14H23NO3Couleur et forme :White Off-White SolidMasse moléculaire :253.16779Plerixafor
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C28H54N8Couleur et forme :White Off-White PowderMasse moléculaire :502.44714Rivaroxaban Desmorpholinone Analog ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18ClN3O4SCouleur et forme :White Off-White SolidMasse moléculaire :395.07065Rotigotine Related Compound K (7,8-Dihydronaphthalen-1-ol)
CAS :Monophenols not elsewhere specified or includedFormule :C10H10OCouleur et forme :White Grey Brown Crystalline SolidMasse moléculaire :146.07316Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22FNO3Couleur et forme :Light Tan PowderMasse moléculaire :343.15837Ondansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Brivaracetam Related Compound B ((R)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White Off-White SolidMasse moléculaire :212.15248Amiodarone Related Compound H (2-chloro-N,N-diethylethanamine hydrochloride)
CAS :3-amino-3-methyl-1-butyne;2-chloro-n,n-dimethyl-ethylamine hydrochloride; 2-(diethylamino) isopropyl chloride hydrochlorideFormule :C6H14ClN·ClHCouleur et forme :Off-White PowderMasse moléculaire :171.05815Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H21NO3·HClCouleur et forme :White PowderMasse moléculaire :347.84Butylated Hydroxytoluene
CAS :Monophenols, nesoiFormule :C15H24OCouleur et forme :White PowderMasse moléculaire :220.18272Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormule :C21H28O5Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :360.19367Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C22H20N4O6Couleur et forme :Light Brown PowderMasse moléculaire :436.13828Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :White Beige PowderMasse moléculaire :315.16569Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White SolidMasse moléculaire :381.07588Gefitinib
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H24ClFN4O3Couleur et forme :White PowderMasse moléculaire :446.1521
![Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1098526.webp&w=3840&q=75)